{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:34:57Z","timestamp":1786365297717,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.resinv.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T23:58:19Z","timestamp":1513036699000},"page":"158-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections"],"prefix":"10.1016","volume":"56","author":[{"given":"Yusuke","family":"Okubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Michihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naho","family":"Morisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Uda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Miyairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2017.11.005_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/AAC.50.2.709-712.2006","article-title":"Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae","volume":"50","author":"Suzuki","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s10156-009-0021-4","article-title":"Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia","volume":"16","author":"Morozumi","year":"2010","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1086\/653535","article-title":"High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infections in China","volume":"51","author":"Cao","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2017.11.005_bib4","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3201\/eid1908.121455","article-title":"Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000\u20132011","volume":"19","author":"Hong","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2017.11.005_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cis784","article-title":"Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children","volume":"55","author":"Okada","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2017.11.005_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jama.1961.03040150034009","article-title":"Eaton agent pneumonia","volume":"176","author":"Kingston","year":"1961","journal-title":"JAMA."},{"key":"10.1016\/j.resinv.2017.11.005_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2017.11.005_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resinv.2017.11.005_bib9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4168\/aair.2014.6.1.22","article-title":"Effects of methylprednisolone pulse therapy on refractory Mycoplasma pneumoniae pneumonia in children","volume":"6","author":"You","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.resinv.2017.11.005_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2017.11.005_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3947\/ic.2014.46.4.239","article-title":"Early additional immune-modulators for Mycoplasma pneumoniae pneumonia in children: an observational study","volume":"46","author":"Youn","year":"2014","journal-title":"Infect Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib12","first-page":"1","article-title":"Clinical epidemiology and health services research using the diagnosis procedure combination database in Japan","volume":"7","author":"Yasunaga","year":"2013","journal-title":"Asian Pac. J. Dis. Manag."},{"key":"10.1016\/j.resinv.2017.11.005_bib13","unstructured":"HCUP Kids' Inpatient Database Comparison Report. Healthcare Cost and Utilization Project Agency for Healthcare Research and Quality. Available at: \u3008https:\/\/www.hcup-us.ahrq.gov\/kidoverview.jsp\u3009. [Accessed 15 April 2017]."},{"key":"10.1016\/j.resinv.2017.11.005_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.resinv.2017.11.005_bib15","unstructured":"The World Health Organization Child Growth Standards. Available at: \u3008http:\/\/www.who.int\/childgrowth\/en\/\u3009. [Accessed 15 April 2017]."},{"key":"10.1016\/j.resinv.2017.11.005_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"Rosenbaum","year":"2012","journal-title":"Am Stat"},{"key":"10.1016\/j.resinv.2017.11.005_bib17","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Communications in statistics","volume":"38","author":"Austin","year":"2009","journal-title":"Simul Comput"},{"key":"10.1016\/j.resinv.2017.11.005_bib18","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/sim.6128","article-title":"Instrumental variable methods for causal inference","volume":"33","author":"Baiocchi","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/j.resinv.2017.11.005_bib19","unstructured":"Mycoplasma pneumonia as of September 2012, Japan. IASR 33: 261-262. Available at: \u3008https:\/\/www.niid.go.jp\/niid\/en\/iasr-vol33-e\/865-iasr\/2738-tpc392.html\u3009. [ accessed 14.06.17]."},{"key":"10.1016\/j.resinv.2017.11.005_bib20","unstructured":"The Committee of Japanese Society of Mycoplasmology. Guiding principles for treating Mycoplasma pneumoniae pneumonia. Available at: \u3008http:\/\/square.umin.ac.jp\/jsm\/Eng%20shisin.pdf\u3009. [Accessed 20 June 2017]."},{"key":"10.1016\/j.resinv.2017.11.005_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2217\/fmb.11.18","article-title":"Mycoplasma pneumoniae: susceptibility and resistance to antibiotics","volume":"4","author":"B\u00e9b\u00e9ar","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.resinv.2017.11.005_bib22","first-page":"12","article-title":"Toxicity studies of tosufloxacin tosilate hydrate in juvenile animals and class effects studies","volume":"58","author":"Furubo","year":"2010","journal-title":"Jan J Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib23","first-page":"288","article-title":"Nakazawa S, Oka S, Sat H, Watanabe O, Niino K. Effects of dry syrup minocycline (Minomycin \u201cLederle\u201d) in the pediatric field","volume":"25","year":"1972","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.resinv.2017.11.005_bib24","first-page":"69","article-title":"Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases","volume":"58","author":"Sunakawa","year":"2010","journal-title":"Jan J Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(66)92683-3","article-title":"Tetracyclines and the teeth","volume":"2","author":"Kwalewska","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.resinv.2017.11.005_bib26","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7883\/yoken.65.535","article-title":"In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumonia isolates from pediatric patients: results from a multicenter surveillance","volume":"65","author":"Akaike","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.resinv.2017.11.005_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.1974.03230310039025","article-title":"Mycoplasma pneumoniae pneumonia and clindamycin therapy. Failure to demonstrate efficacy","volume":"228","author":"Smilack","year":"1974","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2017.11.005_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiac.2014.01.001","article-title":"Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level","volume":"20","author":"Inamura","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2017.11.005_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10156-011-0265-7","article-title":"Clinical implications of interleukin-19 levels in pediatric patients with Mycoplasma pneumoniae pneumonia","volume":"17","author":"Oishi","year":"2011","journal-title":"J Infect Chemother"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451730148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221253451730148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T16:36:51Z","timestamp":1719679011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221253451730148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S221253451730148X"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2017.11.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent trends in practice patterns and impact of corticosteroid use on pediatric Mycoplasma pneumoniae-related respiratory infections","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}